Combination treatment of liposomal amphotericin B and isavuconazole is synergistic in treating experimental mucormycosis

OBJECTIVES: Liposomal amphotericin B (L-AMB) and isavuconazonium sulphate are commonly used antifungal drugs to treat mucormycosis. However, the efficacy of combination therapy of L-AMB/isavuconazonium sulphate versus monotherapy is unknown. We used an immunosuppressed mouse model of pulmonary mucor...

Descripción completa

Detalles Bibliográficos
Autores principales: Gebremariam, Teclegiorgis, Gu, Yiyou, Singh, Shakti, Kitt, Therese M, Ibrahim, Ashraf S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446914/
https://www.ncbi.nlm.nih.gov/pubmed/34263306
http://dx.doi.org/10.1093/jac/dkab233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446914/
https://www.ncbi.nlm.nih.gov/pubmed/34263306
http://dx.doi.org/10.1093/jac/dkab233

Ejemplares similares